U.S. markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.90 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.44 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.53
    -0.18 (-0.39%)
     
  • Gold

    1,781.90
    -23.60 (-1.31%)
     
  • Silver

    22.55
    -0.81 (-3.46%)
     
  • EUR/USD

    1.1963
    +0.0050 (+0.42%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • GBP/USD

    1.3305
    -0.0052 (-0.39%)
     
  • USD/JPY

    104.0350
    -0.2150 (-0.21%)
     
  • BTC-USD

    16,816.82
    +92.02 (+0.55%)
     
  • CMC Crypto 200

    329.10
    -8.40 (-2.49%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Moderna to Test Vaccine Effectiveness

Nov.11 -- The same surge of U.S. covid-19 cases that helped Pfizer reach results for its vaccine trial earlier this week is helping speed along Moderna Inc.’s own tests. The company says it has accumulated enough volunteers to allow a preliminary analysis of its shot. Bloomberg’s Michelle Cortez reports on “Bloomberg Daybreak: Asia.”